Is IRIDEX CORP (IRIX) Halal?

NASDAQ Healthcare United States $17M
✗ NOT HALAL
Confidence: 90/100
IRIDEX CORP (IRIX) is Not Halal under AAOIFI Standard 21. IRIDEX CORP operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 21.8%
/ 30%
11.2%
/ 30%
39.4%
/ 30%
1.11%
/ 5%
✗ NOT HALAL
DJIM 21.8%
/ 33%
11.2%
/ 33%
39.4%
/ 33%
1.11%
/ 5%
✗ NOT HALAL
MSCI 15.9%
/ 33%
8.2%
/ 33%
28.8%
/ 33%
1.11%
/ 5%
✓ HALAL
S&P 21.8%
/ 33%
11.2%
/ 33%
39.4%
/ 33%
1.11%
/ 5%
✗ NOT HALAL
FTSE 15.9%
/ 33%
8.2%
/ 33%
28.8%
/ 50%
1.11%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.26
P/B Ratio
-15.7
EV/EBITDA
-10.4
EV: $22M
Revenue
$49M
Growth: 16.0%
Beta
0.6
Low volatility
Current Ratio
1.9

Profitability

Gross Margin 36.5%
Operating Margin -0.1%
Net Margin -8.4%
Return on Equity (ROE) -126.4%
Return on Assets (ROA) -5.5%

Cash Flow & Balance Sheet

Operating Cash Flow-$7M
Free Cash Flow-$7M
Total Debt$5M
Debt-to-Equity92.1
Current Ratio1.9
Total Assets$29M

Price & Trading

Last Close$1.35
50-Day MA$1.40
200-Day MA$1.19
Avg Volume84K
Beta0.6
52-Week Range
$0.79
$1.65

About IRIDEX CORP (IRIX)

CEO
Mr. Patrick Mercer
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$17M
Currency
USD

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is IRIDEX CORP (IRIX) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), IRIDEX CORP is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is IRIDEX CORP's debt ratio?

IRIDEX CORP's debt ratio is 21.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 15.9%.

What are IRIDEX CORP's key financial metrics?

IRIDEX CORP has a market capitalization of $17M, and revenue of $49M. The company maintains a gross margin of 36.5% and a net margin of -8.4%. Return on equity stands at -126.4%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.